Drugs / LAS41005
last change Jun 2009 re-read 2 minutes ago

LAS41005

Developed for
actinic keratosis
Investigated by
Almirall, S.A.

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00987246 Jun 2008 → Jun 2009 actinic keratosis Almirall, S.A. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LAS41005 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00987246
Route Topical TopicalNCT00987246